Back to Search Start Over

A15 EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY.

Authors :
Feagan, B G
Loftus, E V
Danese, S
Vermeire, S
Sandborn, W J
Ritter, T
Mehta, R
Seidler, U
Seibold, F
Beales, I
Kim, H
McNally, J
Yun, C
Zhao, S
Liu, X
Tasset, C
Besuyen, R
Watanabe, M
Schreiber, S
Rogler, G
Source :
Journal of the Canadian Association of Gastroenterology; 2021 Supplement, Vol. 4, p18-20, 3p
Publication Year :
2021

Details

Language :
English
ISSN :
25152092
Volume :
4
Database :
Complementary Index
Journal :
Journal of the Canadian Association of Gastroenterology
Publication Type :
Academic Journal
Accession number :
149291664
Full Text :
https://doi.org/10.1093/jcag/gwab002.014